What does CUSIP 67576A100 represent in this 13F holders report?

CUSIP 67576A100 is the security identifier for OCUL - OCULAR THERAPEUTIX, INC - Common Stock used to aggregate holder disclosures.

How many institutions held OCUL - OCULAR THERAPEUTIX, INC - Common Stock in Q2 2017?

71 institutional investors reported OCUL - OCULAR THERAPEUTIX, INC - Common Stock for Q2 2017. Use the holders table for investor-level position and value details.

OCULAR THERAPEUTIX, INC - Common Stock (OCUL)

CUSIP: 67576A100

Q2 2017 13F Holders as of 30 Jun 2017

Security type / class: Equity / Common Stock
Total 13F shares: 15,456,517
Total 13F value: $143,279,882
Share change: -2,830,771
Put/Call ratio: 112%
SEC-reported price per share: $9.27
Number of holders: 71
Value change: -$26,251,504
Number of buys: 35
Number of sells: 37
Shares outstanding: 217,539,543

Security key

67576A100

Report period

Q2 2017

Institutions

Top holders

OCUL full security history Ownership snapshot Full 13F holder table OCULAR THERAPEUTIX, INC SEC filings OCULAR THERAPEUTIX, INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of OCUL - OCULAR THERAPEUTIX, INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

JENNISON ASSOCIATES LLC

Disclosed value leader

JENNISON ASSOCIATES LLC

Comparable rows

15/15

Latest evidence

31 Mar 2017

13F Lead comparable stake: 1.5% Showing 1-6 of 15 holder rows.

Quick read

JENNISON ASSOCIATES LLC leads the comparable SEC ownership view at 1.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens JENNISON ASSOCIATES LLC's linked filing trail.

Comparable ownership Top 5

JENNISON ASSOCIATES LLC 1.5%

Versant Venture Management, LLC 1%

SV Health Investors, LLC 0.74%

FMR LLC 0.63%

WELLINGTON MANAGEMENT GROUP LLP 0.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
JENNISON ASSOCIATES LLC	13F Company 13F	1.5%	$29,853,000 3,216,881 shares	—	31 Mar 2017
Versant Venture Management, LLC	13F Company 13F	1%	$20,558,764 2,215,384 shares	—	31 Mar 2017
SV Health Investors, LLC	13F Company 13F	0.74%	$14,896,000 1,605,207 shares	—	31 Mar 2017
FMR LLC	13F Company 13F	0.63%	$12,674,000 1,365,699 shares	—	31 Mar 2017
WELLINGTON MANAGEMENT GROUP LLP	13F Company 13F	0.6%	$12,182,000 1,312,703 shares	—	31 Mar 2017
BlackRock Finance, Inc.	13F Company 13F	0.59%	$11,979,000 1,290,745 shares	—	31 Mar 2017

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

15,456,517

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

Q2 2017 holders

Holder diff

-2

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 value	Q2 2017 value	Value change	Value Chg %